Product Information
GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.4806 per ML under NDC 63323057811. Its NADAC has been published 88 times since Dec 18, 2024.
FDA first approved this application on Oct 27, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
.2 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323057811
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA209328FDA Approved
10/27/2017
TE Code
AP
On Market Since
10/27/2017
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 88 times since Dec 18, 2024, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4806 per ML |
|---|---|
| All-time high | $1.5856 (Aug 13, 2025) |
| All-time low | $1.2855 (May 20, 2026) |
| 52-week high | $1.5137 |
| 52-week low | $1.2855 |
| Median price | $1.4783 |
| Average price | $1.4521 |
| Largest weekly change | -14.9% (Mar 18, 2026) |
| Weeks tracked | 88 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.4806 per ML (NDC 63323057811), effective Aug 19, 2026.
How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 5.9%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?
Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.2855 (May 20, 2026) to a high of $1.5856 (Aug 13, 2025), with a median of $1.4783 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYCOPYRROLATE 0.2 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?
GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 63323057811) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.